Miyano Go, Koga Hiroyuki, Okawada Manabu, Doi Takashi, Sueyoshi Ryo, Nakamura Hiroki, Seo Shogo, Ochi Takanori, Yamada Susumu, Imaizumi Takaaki, Lane Geoffrey J, Okazaki Tadaharu, Urao Masahiko, Yamataka Atsuyuki
Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo, Japan.
J Pediatr Surg. 2015 Dec;50(12):2041-3. doi: 10.1016/j.jpedsurg.2015.08.022. Epub 2015 Aug 28.
In 2007, we began using the anorectal line (ARL) as the landmark for commencing rectal mucosal dissection (RMD) instead of the dentate line (DL) during laparoscopy-assisted transanal pull-through (L-TAPT) for Hirschsprung's disease (HD). We conducted a medium-term prospective comparison of postoperative fecal continence (POFC) between DL and ARL cases to follow our short-term study.
POFC is assessed by scoring frequency of motions, severity of staining, severity of perianal erosions, anal shape, requirement for medications, sensation of rectal fullness, and ability to distinguish flatus from stool on a scale of 0 to 2 (maximum: 14).
Patient demographics were similar for ARL (2007-2014: n=33) and DL (1997-2006: n=41). There were no intraoperative complications and 2 cases of postoperative colitis in both ARL (6.1%) and DL (4.9%). Mean annual medium-term POFC scores for the 4-7 term of this study were consistently better in ARL: 9.7±1.4*, 10.1±1.6*, 10.6±1.6, and 11.3±1.4* in ARL and 8.6±1.5, 9.1±1.6, 9.8±1.9, 10.0±1.6 in DL (*: p<0.05).
Medium-term POFC is better when the ARL is used as the landmark for RMD during L-TAPT for HD.
2007年,我们在腹腔镜辅助经肛门拖出术(L-TAPT)治疗先天性巨结肠(HD)时,开始使用肛管直肠线(ARL)作为直肠黏膜剥离术(RMD)起始的标志,而非齿状线(DL)。我们开展了一项中期前瞻性研究,比较DL和ARL病例术后的大便失禁情况(POFC),以延续我们的短期研究。
通过对排便频率、染色严重程度、肛周糜烂严重程度、肛门形状、用药需求、直肠胀满感以及区分屁和大便的能力进行评分,评分范围为0至2分(满分:14分)来评估POFC。
ARL组(2007 - 2014年:n = 33)和DL组(1997 - 2006年:n = 41)的患者人口统计学特征相似。两组均无术中并发症,ARL组(6.1%)和DL组(4.9%)各有2例术后结肠炎。在本研究的第4至7期,ARL组的中期平均年度POFC评分始终更高:ARL组分别为9.7±1.4*、10.1±1.6*、10.6±1.6和11.3±1.4*,DL组分别为8.6±1.5、9.1±1.6、9.8±1.9、10.0±1.6(*:p<0.05)。
在L-TAPT治疗HD时,将ARL用作RMD的标志,中期POFC情况更佳。